Efficiency of uterine artery embolization in patients with placenta accreta
- Authors: Marchenko R.N.1,2, Kukarskaya I.I.1,2, Erbaktanova T.A.3
-
Affiliations:
- Tyumen State Medical University
- Perinatal Center
- Mother and Child Hospital
- Issue: Vol 22, No 6 (2020)
- Pages: 25-27
- Section: Articles
- URL: https://journal-vniispk.ru/2075-1753/article/view/95271
- DOI: https://doi.org/10.26442/20751753.2020.6.200303
- ID: 95271
Cite item
Full Text
Abstract
Aim. Evaluation of the effectiveness of uterine artery embolization in patients with placental increment. Material and methods. In the course of the study, a prospective multivariate analysis of 147 individual cards of pregnant women with placental increment was performed against various hemostasis methods: group 1 - embolization of the uterine arteries, group 2 - hysterectomy, group 3 - surgical hemostasis without hysterectomy. In the course of the work, the level of intraoperative blood loss, as well as the uterine vascular bed after embolization, was assessed. Statistical data processing was performed using the Statistica 6 program. Results. Minimal blood loss was noted after uterine artery embolization. When compared with patients who underwent hysterectomy and surgical hemostasis, the volume of blood loss was lower by 17,7 and 9,6%, respectively. The earliest restoration of the uterine vascular bed was registered in a group of patients who underwent uterine artery embolization, which is confirmed by vascular resistance indices in the radial and uterine arteries. Conclusion. Embolization of the uterine arteries is an effective organ-preserving technique that promotes effective hemostasis, as well as the rapid restoration of the uterine vascular bed. Key words: placental increment, uterine artery embolization, intraoperative blood loss, vascular resistance. For citation: Marchenko R.N., Kukarskaya I.I., Erbaktanova T.A. Efficiency of uterine artery embolization in patients with placenta accreta. Consilium Medicum. 2020; 22 (6): 25-27. DOI: 10.26442/20751753.2020.6.200303
Full Text
##article.viewOnOriginalSite##About the authors
Roman N. Marchenko
Tyumen State Medical University; Perinatal Center
Email: vrach08@rambler.ru
аспирант каф. акушерства, гинекологии и реаниматологии с курсом клинико-лабораторной диагностики
Irina I. Kukarskaya
Tyumen State Medical University; Perinatal Center
Tatyana A. Erbaktanova
Mother and Child Hospitalканд. мед. наук, глав. врач Клинического госпиталя
References
- Warrick CM, Rollins MD. Peripartum Anesthesia Considerations for Placenta Accreta. Clin Obstet Gynecol 2018; 61 (4): 808-27.
- Creanga AA, Bateman BT, Butwick AJ et al. Morbidity associated with cesarean delivery in the United States: is placenta accreta an increasingly important contributor? Am J Obstet Gynecol 2015; 213 (3): 384. e1-11.
- Maymon S, Maymon R, Bornstein J et al. Comparison of two approaches for placenta accreta: uterine preservation versus cesarean hysterectomy. Harefuah 2018; 157 (11): 696-700.
- Farasatinasab M, Moghaddas A, Dashti-Khadivaki S et al. Management of Abnormal Placenta Implantation with Methotrexate: A Review of Published Data. Gynecol Obstet Invest 2016; 81 (6): 481-96.
- Wang YL, Weng SS, Huang WC. First-trimester abortion complicated with placenta accreta: A systematic review. Taiwan J Obstet Gynecol 2019; 58 (1): 10-4.
- Carusi DA. The Placenta Accreta Spectrum: Epidemiology and Risk Factors. Clin Obstet Gynecol 2018; 61 (4): 733-42.
- Sun W, Yu L, Liu S et al. Comparison of maternal and neonatal outcomes for patients with placenta accreta spectrum between online-to-offline management model with standard care model. Eur J Obstet Gynecol Reprod Biol 2018; 222: 161-5.
- Reda A. Comments on: Conservative Surgical Treatment of a Case of Placenta Accreta. Rev Bras Ginecol Obstet 2018; 40 (10): 654-5.
- Long Y Chen Y, Fu XQ et al. Research on the expression of MRNA-518b in the pathogenesis of placenta accreta. Eur Rev Med Pharmacol Sci 2019; 23 (1): 23-8.
- Xu JQ. Effectiveness of embolization of the internal iliac or uterine arteries in the treatment of massive obstetrical and gynecological hemorrhages. Eur Rev Med Pharmacol Sci 2015; 19: 372-4.
- Курцер М.А., Бреслав И.Ю., Григорян А.М. и др. Актуальные вопросы лечения послеродовых кровотечений в акушерстве. Мед. алфавит. 2018; 1 (9): 14-7.
- Зверев Д.А. Методика временной эндоваскулярной эмболизации маточных артерий при оперативном родоразрешении. Евразийский союз ученых. 2014; 8-6: 24-5.
- Виницкий А.А., Шмаков Р.Г. Современные представления об этиопатогенезе врастания плаценты и перспективы его прогнозирования молекулярными методами диагностики. Акушерство и гинекология. 2017; 2: 5-10.
- Хасанов А.А. Диагностика, профилактика и органосохраняющие методы родоразрешения беременных с врастанием плаценты. Казанский мед. журн. 2016; 97 (4): 477-85.
- Олейникова О.Н. Оценка эффективности эмболизации маточных артерий при маточных кровотечениях различной этиологии. АГ-Инфо, 2009; 2: 38-42.
- Шадрин Р.В., Шумова М.А., Кулик В.В., Назарян Г.С. Органосохраняющие операции у беременных с врастанием плаценты: наш опыт. Науч. вестн. здравоохранения Кубани. 2017; 2 (50): 108-16.
- Дикун Т.В., Брагинец А.С., Терпелова А.С. и др. Эмболизация маточных артерий как метод лечения миомы матки. Молодой ученый. 2018; 16: 24-5.
Supplementary files
